Elizabeth Caine

Elizabeth received her Ph.D. in Comparative Biomedical Sciences from the University of Wisconsin–Madison and completed a postdoctoral fellowship at Washington University School of Medicine in St. Louis studying RNA virus pathogenesis. She has spent seven years at Promega Corporation, where she is a Senior Scientist in the Functional Proteomics group. Her work focuses on developing technologies and conducting research in induced proximity, particularly targeted protein degradation, to support drug discovery.